Clinical Research at The Liver Institute at Methodist Dallas
An active program in clinical research continues to grow in both local
and national recognition and enhances patient care at The Liver Institute.
The Liver Institute at Methodist Dallas is currently involved in several
research projects regarding treatments for patients with chronic hepatitis
C, hepatitis B, and other liver diseases.
In August 2011, The Liver Institute announced it is involved in several
clinical trials using a newer generation of drugs for the treatment of
chronic hepatitis C. The trials will focus on a second generation of direct-acting
antiviral drugs for hepatitis C that are very potent and may shorten the
duration of therapy in a number of patients. These antiviral drugs offer
very promising hope for eradication of hepatitis C for patients who have
experienced and failed treatment in the past.
Read Liver Transplantation for Hepatocellular Carcinoma (HCC) from the book
Liver Transplantation - Basic Issues by Dr. Alejandro Mejia, Dr. Hector Nazario, and Dr. Parvez Mantry.
Referral Center
The Liver Institute at Methodist Dallas is a major tertiary referral center
for North Texas and the surrounding regions. Independently practicing
physicians at The Liver Institute at Methodist Dallas are available to
meet the needs of both referring physicians and patients alike.